Oct. 4, 2024
The American College of Radiology® (ACR®) is now participating in the U.S. Food and Drug Administration (FDA) Total Product Life Cycle Advisory Program (TAP) pilot, corresponding with the expansion of the program to include radiology devices. The goal of the collaboration is to increase access for radiologists and their patients to safe, effective and clinically meaningful radiology device innovations, including — but not limited to — certain artificial intelligence (AI)-enabled software devices and other cutting-edge technologies.

The TAP pilot is an engagement program focused on providing innovators of various sizes with strategic input in the areas of patient engagement, clinical evidence development, clinical practice and new technology adoption, and reimbursement. The program is initially limited to certain devices with “Breakthrough Device” designations. It expanded from cardiology device exclusivity to include neurology, ophthalmology and radiology devices.

More information about initiatives to advance radiology AI is on the ACR Data Science Institute® website. For questions about digital health regulatory policy, contact Michael Peters, ACR Senior Director, Government Affairs.

Related ACR News

  • Report Supply Chain Issues to the ACR Quick Response Team

    The American College of Radiology® (ACR®) and its members can work together to overcome supply chain issues and preserve patient access to high-quality care.

    Read more
  • Focus on Scope: Latest Status of State Healthcare-Related Bills

    Overview of status of several bills in this year’s state legislative sessions related to scope of practice.

    Read more
  • Participate in the Healthcare AI Challenge at ACR 2025

    Call for ACR 2025 attendees to participate in healthcare AI challenge at the upcoming meeting.

    Read more